BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28770105)

  • 1. Multi-parametric profiling of renal cell, colorectal, and ovarian cancer identifies tumour-type-specific stroma phenotypes and a novel vascular biomarker.
    Corvigno S; Frödin M; Wisman GBA; Nijman HW; Van der Zee AG; Jirström K; Nodin B; Hrynchyk I; Edler D; Ragnhammar P; Johansson M; Dahlstrand H; Mezheyeuski A; Östman A
    J Pathol Clin Res; 2017 Jul; 3(3):214-224. PubMed ID: 28770105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma.
    Frödin M; Mezheyeuski A; Corvigno S; Harmenberg U; Sandström P; Egevad L; Johansson M; Östman A
    Br J Cancer; 2017 Jan; 116(2):195-201. PubMed ID: 27931046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer.
    Mezheyeuski A; Bradic Lindh M; Guren TK; Dragomir A; Pfeiffer P; Kure EH; Ikdahl T; Skovlund E; Corvigno S; Strell C; Pietras K; Ponten F; Mulder J; Qvortrup C; Portyanko A; Tveit KM; Glimelius B; Sorbye H; Östman A
    Oncotarget; 2016 Jul; 7(27):41948-41958. PubMed ID: 27248825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of fibroblast-rich tumor stroma and perivascular cells in serous ovarian cancer: Inter- and intra-patient heterogeneity and impact on survival.
    Corvigno S; Wisman GB; Mezheyeuski A; van der Zee AG; Nijman HW; Åvall-Lundqvist E; Östman A; Dahlstrand H
    Oncotarget; 2016 Apr; 7(14):18573-84. PubMed ID: 26918345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma vascular endothelial but not fibroblast growth factor levels correlate with colorectal liver mestastasis vascularity and volume.
    Davies MM; Jonas SK; Kaur S; Allen-Mersh TG
    Br J Cancer; 2000 Mar; 82(5):1004-8. PubMed ID: 10737380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components.
    Ioachim E; Michael MC; Salmas M; Damala K; Tsanou E; Michael MM; Malamou-Mitsi V; Stavropoulos NE
    BMC Cancer; 2006 May; 6():140. PubMed ID: 16732887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asporin is a stromally expressed marker associated with prostate cancer progression.
    Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
    Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvascular proliferation is associated with aggressive tumour features and reduced survival in lung adenocarcinoma.
    Ramnefjell M; Aamelfot C; Aziz S; Helgeland L; Akslen LA
    J Pathol Clin Res; 2017 Oct; 3(4):249-257. PubMed ID: 29085665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF-C and VEGF-D overexpression is more common in left-sided and well-differentiated colon adenocarcinoma.
    Szajewski M; Kruszewski WJ; Lakomy J; Ciesielski M; Kawecki K; Jankun J; Buczek T; Szefel J
    Oncol Rep; 2014 Jan; 31(1):125-30. PubMed ID: 24173916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer.
    West AF; O'Donnell M; Charlton RG; Neal DE; Leung HY
    Br J Cancer; 2001 Aug; 85(4):576-83. PubMed ID: 11506499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroma AReactive Invasion Front Areas (SARIFA): a novel histopathologic biomarker in colorectal cancer patients and its association with the luminal tumour proportion.
    Reitsam NG; Grosser B; Enke JS; Mueller W; Westwood A; West NP; Quirke P; Märkl B; Grabsch HI
    Transl Oncol; 2024 Jun; 44():101913. PubMed ID: 38593584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of tumour-stroma ratio in endometrial carcinoma.
    Panayiotou H; Orsi NM; Thygesen HH; Wright AI; Winder M; Hutson R; Cummings M
    BMC Cancer; 2015 Dec; 15():955. PubMed ID: 26674153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF/VEGFR2 and PDGF-B/PDGFR-β expression in non-metastatic renal cell carcinoma: a retrospective study in 1,091 consecutive patients.
    Song SH; Jeong IG; You D; Hong JH; Hong B; Song C; Jung WY; Cho YM; Ahn H; Kim CS
    Int J Clin Exp Pathol; 2014; 7(11):7681-9. PubMed ID: 25550804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of stromal genes associated with the angiogenic response are not differentiated between human tumour xenografts with divergent vascular morphologies.
    Farren M; Weston S; Brown H; Broadbent N; Powell S; Shaw R; Smith NR; Inglis R; Graham A; Ashton S; Wedge SR; Barry ST
    Angiogenesis; 2012 Dec; 15(4):555-68. PubMed ID: 22644562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter- and intra-tumoral relationships between vasculature characteristics, GLUT1 and budding in colorectal carcinoma.
    Mezheyeuski A; Nerovnya A; Bich T; Tur G; Ostman A; Portyanko A
    Histol Histopathol; 2015 Oct; 30(10):1203-11. PubMed ID: 25811313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that the p53 negative / Bcl-2 positive phenotype is an independent indicator of good prognosis in colorectal cancer: a tissue microarray study of 460 patients.
    Watson NF; Madjd Z; Scrimegour D; Spendlove I; Ellis IO; Scholefield JH; Durrant LG
    World J Surg Oncol; 2005 Jul; 3():47. PubMed ID: 16029489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood.
    Bremnes RM; Camps C; Sirera R
    Lung Cancer; 2006 Feb; 51(2):143-58. PubMed ID: 16360975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc.
    Kuhn W; Schmalfeldt B; Reuning U; Pache L; Berger U; Ulm K; Harbeck N; Späthe K; Dettmar P; Höfler H; Jänicke F; Schmitt M; Graeff H
    Br J Cancer; 1999 Apr; 79(11-12):1746-51. PubMed ID: 10206287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell lymphoma 2 and β-catenin expression in colorectal cancer and their prognostic role following surgery.
    Balzi M; Ringressi MN; Faraoni P; Booth C; Taddei A; Boni L; Bechi P
    Mol Med Rep; 2015 Jul; 12(1):553-60. PubMed ID: 25738398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.